Table 3

Summary of PK parameters for rFVIIIFc and rFVIII in hemophilia A dogs

TreatmentCmax, IU/mLCmax, ng/mLAUC, h × IU/mLAUC, h × ng/mLT1/2, hCL, mL/h/kgVss, mL/kg
PK by FVIII activity measurement        
    rFVIIIFc* 2.0 ± 0.54  25.9 ± 6.47  15.4 ± 0.3 5.1 ± 1.4 86.4 ± 14.0 
    rFVIII 2.0  18.2  7.4 6.5 64.0 
PK by rFVIII and rFVIIIFc Ag measurement        
    rFVIIIFc*  210 ± 33  2481 ± 970 15.7 ± 1.7 6.2 ± 3.0 86.1 ± 19.2 
    rFVIII  211  1545 6.9 8.7 80.7 
TreatmentCmax, IU/mLCmax, ng/mLAUC, h × IU/mLAUC, h × ng/mLT1/2, hCL, mL/h/kgVss, mL/kg
PK by FVIII activity measurement        
    rFVIIIFc* 2.0 ± 0.54  25.9 ± 6.47  15.4 ± 0.3 5.1 ± 1.4 86.4 ± 14.0 
    rFVIII 2.0  18.2  7.4 6.5 64.0 
PK by rFVIII and rFVIIIFc Ag measurement        
    rFVIIIFc*  210 ± 33  2481 ± 970 15.7 ± 1.7 6.2 ± 3.0 86.1 ± 19.2 
    rFVIII  211  1545 6.9 8.7 80.7 

See Table 2 for expansion of abbreviations.

*

Results presented are mean ± SD from 4 dogs.

Results presented are mean. SD not reported since 2 dogs were used.

or Create an Account

Close Modal
Close Modal